Ian Eliason

Co-founded a venture capital fund at 22. Structured an immunotherapy spinout from a research institute — ~$350M in grants and contracts. Advised 12 companies that collectively raised over $110M.

Now building businesses that operate on their own.

Subscribe to the memo →